These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep. Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713 [TBL] [Abstract][Full Text] [Related]
4. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection. Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976 [TBL] [Abstract][Full Text] [Related]
5. Response of sheep to challenge infection with Fasciola hepatica. Sandeman RM; Howell MJ Res Vet Sci; 1981 May; 30(3):294-7. PubMed ID: 6114523 [TBL] [Abstract][Full Text] [Related]
6. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke. Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823 [TBL] [Abstract][Full Text] [Related]
7. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep. Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261 [TBL] [Abstract][Full Text] [Related]
8. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592 [TBL] [Abstract][Full Text] [Related]
9. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections. Oldham G Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998 [TBL] [Abstract][Full Text] [Related]
10. Fasciola hepatica: studies on vaccination of rats and mice with a surface antigen prepared from fluke homogenate by means of a monoclonal antibody. Hanna RE; Anderson A; Trudgett AG Res Vet Sci; 1988 Mar; 44(2):237-41. PubMed ID: 3291030 [TBL] [Abstract][Full Text] [Related]
11. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae. Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants. Mulcahy G; Dalton JP Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858 [TBL] [Abstract][Full Text] [Related]
13. Antibody response in cattle, sheep and rats to infection with gamma-irradiated metacercariae of Fasciola hepatica. Hughes DL; Hanna RE; Doy TG Res Vet Sci; 1982 May; 32(3):354-8. PubMed ID: 7100653 [TBL] [Abstract][Full Text] [Related]
14. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species. Phiri IK; Phiri AM; Harrison LJ Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844 [TBL] [Abstract][Full Text] [Related]
15. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica. Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793 [TBL] [Abstract][Full Text] [Related]
16. The serum glucose and beta-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection. Phiri IK; Phiri AM; Harrison LJ Vet Parasitol; 2007 Feb; 143(3-4):287-93. PubMed ID: 17011709 [TBL] [Abstract][Full Text] [Related]
17. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica. López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471 [TBL] [Abstract][Full Text] [Related]
18. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica. Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548 [TBL] [Abstract][Full Text] [Related]
19. The resistance of sheep to Fasciola hepatica: studies on the pathophysiology of challenge infections. Sinclair KB Res Vet Sci; 1975 Nov; 19(3):296-303. PubMed ID: 1061964 [TBL] [Abstract][Full Text] [Related]
20. Chronic subclinical ovine fascioliasis: plasma glutamate dehydrogenase, gamma-glutamyl transpeptidase and aspartate aminotransferase activities and their significance as diagnostic aids. Sykes AR; Coop RL; Robinson MG Res Vet Sci; 1980 Jan; 28(1):71-5. PubMed ID: 6103569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]